|
PLEKHM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.42583730880597E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6769918786963E-12 |
| Normal-vs-Stage2 |
2.602600E-03 |
| Normal-vs-Stage3 |
4.77260453379813E-11 |
| Normal-vs-Stage4 |
8.00349786445054E-11 |
| Stage1-vs-Stage2 |
7.982100E-02 |
| Stage1-vs-Stage3 |
5.616200E-01 |
| Stage1-vs-Stage4 |
1.864990E-01 |
| Stage2-vs-Stage3 |
5.164300E-02 |
| Stage2-vs-Stage4 |
1.639600E-02 |
| Stage3-vs-Stage4 |
4.132800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68887126505979E-12 |
| Normal-vs-AfricanAmerican |
2.49169573862673E-11 |
| Normal-vs-Asian |
8.63370042125666E-10 |
| Caucasian-vs-AfricanAmerican |
4.956300E-02 |
| Caucasian-vs-Asian |
1.592980E-01 |
| AfricanAmerican-vs-Asian |
4.236200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.45530254513915E-11 |
| Normal-vs-Female |
1.41742173553894E-12 |
| Male-vs-Female |
3.774200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.87692092371117E-12 |
| Normal-vs-Age(41-60Yrs) |
6.79667433445275E-12 |
| Normal-vs-Age(61-80Yrs) |
5.90149999979417E-08 |
| Normal-vs-Age(81-100Yrs) |
6.756600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.238000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.742430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.410200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.396200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.444400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.910600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.969400E-01 |
| Classical-VS-Follicular |
2.38560282639355E-11 |
| Classical-VS-Other |
1.502380E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
9.94530000000271E-05 |
| Tall-VS-Other |
1.032020E-01 |
| Tall-VS-Normal |
7.00880020687578E-10 |
| Follicular-VS-Other |
4.487600E-01 |
| Follicular-VS-Normal |
6.656200E-02 |
| Other-VS-Normal |
3.021700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.46999984301988E-10 |
| Normal-vs-N1 |
3.48029999996946E-06 |
| N0-vs-N1 |
8.944200E-01 |
|
|
